Emergent BioSolutions (EBS) Raw Materials (2011 - 2018)

Emergent BioSolutions' Raw Materials history runs 8 years deep, the most recent figure standing at $51.8 million for Q4 2018.

• On a quarterly basis, Raw Materials rose 43.49% year-over-year to $51.8 million in Q4 2018; TTM through Dec 2018 was $51.8 million, a 43.49% increase from a year earlier, with the FY2018 full-year figure at $51.8 million, up 43.49% from the prior year.
• Raw Materials grew to $51.8 million in Q4 2018 per EBS's latest filing, from $33.8 million in the prior quarter.
• Across five years, Raw Materials topped out at $51.8 million in Q4 2018 and bottomed at $15.0 million in Q2 2014.
• The 5-year median for Raw Materials is $29.3 million (2016), against an average of $27.5 million.
• Across the five-year window, Raw Materials soared 614.81% in 2014 and decreased 7.19% in 2015, its largest moves.
• Year by year, Raw Materials stood at $17.4 million in 2014, then climbed by 22.45% to $21.3 million in 2015, then soared by 44.24% to $30.7 million in 2016, then climbed by 17.64% to $36.1 million in 2017, then jumped by 43.49% to $51.8 million in 2018.
• Per Business Quant, the three latest EBS Raw Materials figures stand at $51.8 million (Q4 2018), $33.8 million (Q3 2018), and $34.4 million (Q2 2018).